In this recorded presentation from November 16th, 2021, Dr. Fred Appelbaum provides updates on AML treatment and discusses important questions moving forward. By the end of the presentation, participants will gain a better understanding of the molecular basis for AML and disparities in AML treatments and learn about expected outcomes of approved therapies.
Presenter: Dr. Fred Appelbaum
Contact Hours Offered: No CEs offered for this webinar
View the Presentation
This webinar is available on-demand. Webinars from the Fred Hutch Clinical CE Library are accessible to Fred Hutch employees, as well as academic and clinical partners. View the presentation by following the link that best applies to your login credentials.